Breaking into equity capital markets

What equity capital markets actually does

Equity capital markets is the product group that helps companies raise money by selling stock, or by selling something that behaves partly like stock, to public and private investors. An initial public offering is the deal most people think of first, but ECM's mandate is much wider: a public company issuing more shares a few years after its IPO, a private equity sponsor selling down its remaining stake in a company it took public last year, a founder's family office quietly disposing of a large block overnight, and a company raising a convertible bond instead of straight debt all run through the same group. If a transaction involves a company issuing or an existing holder selling equity or an equity-linked security to the market, ECM is in the room.

That single mandate, raise or sell equity, hides a surprising amount of range, which is exactly why ECM is worth taking seriously as a seat rather than treating it as "the group that does IPOs." An ECM banker working an active year might help price a first-time IPO for a company nobody outside its own industry has heard of, structure a convertible bond for a mature company trying to avoid diluting shareholders at a depressed stock price, and execute an overnight block trade for a private equity sponsor exiting a position, all inside the same quarter. Understanding what ECM bankers actually do day to day is the natural starting point before any of the mechanics below make sense.

Candidates gravitate to ECM for a specific combination of reasons that hold up under scrutiny. Deal cycles are shorter than M&A: a follow-on offering can be marketed and priced inside a single week, sometimes inside a single night, compared to the many months a sale process typically takes, which means junior bankers see many more live transactions actually close in a given year. The work sits closer to the market than most banking seats, rewarding people who like reading investor sentiment and price action alongside building models, which is a genuinely different skill mix than the pure deal-structuring emphasis of M&A or the credit-underwriting emphasis of leveraged finance. And ECM is where banking meets sales and trading most directly, giving junior bankers exposure to how institutional investors actually think about a stock, not just how a banker thinks a company should be valued on paper.

The reasons that do not hold up as well, and that a sharp interviewer will probe: ECM deal volume is unusually sensitive to whether markets are open for new issuance, so a candidate's year-to-year experience can vary more than in other product groups depending on when they happen to be staffed. A generic "I like the stock market" answer is also a weak one, since it says nothing about whether you understand pricing mechanics, syndicate structure, or the actual products ECM sells; see how to answer why ECM for what a genuinely specific answer sounds like instead.

Where ECM sits in the bank

ECM is a product group, meaning it is organized around a type of transaction rather than an industry, the same way M&A and leveraged finance are product groups while a group like TMT or healthcare is a coverage group organized around a sector. A coverage banker who has spent years building a relationship with a technology company's CFO is the first call when that company decides to do something; when the something turns out to be raising equity, the coverage banker brings in ECM to actually structure, price, and sell the deal. ECM staffs across every sector: the same ECM team that prices a biotech IPO this month might price an industrial company's follow-on offering next month, contributing capital markets expertise regardless of which coverage group originated the mandate.

What makes ECM structurally distinct from M&A or leveraged finance is that it sits between two other parts of the bank, not just between the client and the deal. On one side is the coverage banker, who owns the client relationship and brought the mandate in. On the other side is the sales and trading floor, specifically the equity sales force and the trading desk, who own the relationships with the institutional investors who will actually buy the securities. ECM's job is to translate between the two: advising the client on what a realistic price and structure looks like given what investors are actually willing to pay, and advising the investors on why the deal is attractive given what the company is actually worth. Neither a pure coverage banker nor a pure trader could do this translation alone, which is why ECM exists as its own seat rather than being absorbed into either side.

This translation role splits into two functions inside ECM itself, and understanding the split is close to a prerequisite for every other article in this guide.

Origination bankers spend their time closer to a traditional banking role: building the models and materials that convince a company's board a deal makes sense, advising on timing, size, and structure, and managing the workstream once a deal is a live mandate. Syndicate, sometimes simply called "the syndicate desk," sits much closer to the trading floor physically and culturally: once a deal launches, syndicate bankers are the ones building the order book in real time during a roadshow, deciding how to allocate a scarce, oversubscribed deal among investors who all want more stock than they will get, and managing the stock's performance in the days immediately after it starts trading. How the syndicate desk works covers this side of the business in full, including the bookbuilding and allocation mechanics that come up constantly in ECM interviews.

A useful shorthand: origination sells the deal to the company, syndicate sells the deal to the market. Both are ECM, both are essential to any transaction actually closing, and most ECM analysts and associates rotate through exposure to both sides even if a given bank formally separates the two desks.

A related point interviewers expect you to know: because a company can return to the equity market repeatedly, an IPO is rarely a one-off engagement for the bank that leads it. The lead underwriters that price an IPO typically get first call on that company's next follow-on, its eventual convertible issuance if it chooses that path, and any secondary block trade its early investors want to run down the line, so the relationship value of doing a good job on a first deal compounds well beyond the fee on that single transaction. This is part of why syndicate desks care so much about how a deal trades in its first weeks: a botched IPO that leaves investors underwater can cost the bank future mandates from the same issuer, not just goodwill on the deal at hand.

The product landscape

The single biggest mistake candidates make in ECM interviews is treating every deal as "basically an IPO." It is not. Each ECM product has a different risk profile, a different marketing process, and a different fee structure, and interviewers test whether you understand those differences rather than accepting a generic description of "helping companies raise equity."

Reading down that table, the products separate cleanly along two axes: how much marketing the deal requires (an IPO needs a full roadshow, a block trade needs almost none) and how much risk the bank itself takes on (a marketed deal is priced with real-time investor feedback, while a block trade or a "bought deal" commits the bank's own capital before it knows for certain it can resell the position). The IPO process, end to end walks through the most marketing-intensive product in detail, while follow-ons and block trades covers the full spectrum from a fully marketed follow-on down to an overnight block. Convertible bonds, explained for bankers covers the most structurally distinct product on the list, since a convert is priced off a credit spread and an embedded equity option at the same time, not off a stock price alone.

One distinction cuts across every row in that table and is worth stating explicitly. A company can raise capital through primary shares, newly issued stock that dilutes existing holders and puts fresh cash on the company's balance sheet, or existing holders can sell secondary shares, which raises no new capital for the company and simply changes who owns the stock. Many IPOs and follow-ons blend both, a company selling new primary shares to fund its business alongside an early investor or founder selling down part of an existing stake in the same offering. Interviewers sometimes ask candidates to explain why a company's board would agree to include a secondary component in its own IPO: it is usually a negotiated accommodation that lets an early venture capital or private equity backer begin realizing a return without waiting for a full lockup expiration and a separate follow-on process later.

Convertible bonds also sit at a genuine border between two product groups, since a convert is a debt instrument with an equity feature attached, and how ECM and debt capital markets (DCM) actually divide that work, alongside how both compare to M&A, is covered in ECM vs. DCM vs. M&A.

Two more structures round out the ECM product set without fitting neatly into the table above. A direct listing lets existing shareholders begin trading their shares on an exchange without the company selling new primary shares or running a traditional roadshow, and a SPAC merger takes a private company public by merging it into an already-listed shell company rather than filing a traditional IPO registration. Both are mechanically distinct enough from a traditional IPO that they get their own treatment in direct listings and SPACs: the mechanics.

How valuation and pricing work in ECM

A distinction that trips up almost every candidate coming from a pure valuation background: pricing a deal is not the same exercise as valuing a company, even though the second feeds into the first.

Valuing a company is analytical. You build a comparable companies analysis, maybe a discounted cash flow, and arrive at a defensible range of what the business is intrinsically worth, largely independent of any specific transaction. Pricing a deal starts from that same range but then layers a market exercise on top of it. An ECM banker has to ask a different set of questions: what will investors actually pay for this stock today, given everything else competing for their capital this week? How much of a new-issue discount does a stock with no trading history need to offer for long-only funds and hedge funds to commit real money to an order before they can see how the stock trades? And critically, what price lets the stock perform reasonably well in the aftermarket, since a company planning to raise capital again in the future needs this deal's investors to make money, not just this deal's underwriters to collect a fee?

That aftermarket consideration is why IPOs typically price at a discount to where bankers privately expect the stock to trade once it opens. Price too aggressively (too high) and a soft aftermarket burns investors who bought the deal, damaging the company's and the underwriters' credibility for the next raise. Price too conservatively (too low) and the company leaves money on the table, and a stock that pops enormously on day one becomes its own story, one where a company's board reasonably asks why the underwriters didn't price it higher. Threading that needle in real time, using order book data collected during a roadshow rather than a static valuation model, is the technical core of the job, and it is covered in depth in how an IPO actually gets valued and priced.

Convertible bonds add a second pricing dimension entirely. A convert has to be priced as a bond, off a credit spread reflecting the issuer's default risk, and as an embedded option, reflecting the value of the right to convert into equity if the stock rises far enough. Move the coupon, the conversion premium (how far above today's stock price the conversion price sits), or the maturity, and both the bond value and the option value shift in opposite directions, which is why structuring a convertible genuinely is a different technical exercise than pricing a straight equity deal, not just a variation on the same theme. Convertible bonds, explained for bankers works through that structuring logic with a full hypothetical.

Two further considerations shape the price beyond the raw comparable companies range. The first is float, the portion of a company's shares actually available to trade publicly rather than held by insiders subject to a lockup; a smaller float can support a technically higher price in the very short term simply because less stock is available to sell, but it also tends to make the stock more volatile once the lockup expires and more shares become sellable at once. The second is investor appetite for new issuance broadly at that moment, independent of the specific company's fundamentals, which is why the same company might price meaningfully differently launching into a receptive market window than into a hesitant one.

Deal dynamics you must know

Three dynamics show up constantly in ECM interviews because they have no clean equivalent in M&A or leveraged finance, and interviewers use them to separate candidates who understand markets from candidates who have only studied deal mechanics on paper.

The first is market windows. Equity issuance is voluntary and time-sensitive in a way that a merger typically is not: a company does not have to raise equity today, so it waits for a "window," a stretch of time when volatility is low enough and investor risk appetite is high enough that a deal is likely to be well received. When broad market conditions turn hostile, whether from a volatility spike or simply a stretch of poor performance among recently issued deals, the ECM new-issue calendar can go quiet for weeks or months, and bankers who had been marketing a deal will advise a client to postpone rather than launch into a market that is unlikely to reward it. Reading and advising on these windows, not just executing a deal once launched, is a distinct skill ECM bankers develop, and it is covered fully in market windows and deal timing.

The second is allocation, the process of deciding who actually gets stock once a deal is oversubscribed, which is nearly always the case for a well-received deal. Not every investor who places an order gets the full amount, or sometimes any amount, and how the syndicate desk splits scarce shares among long-only mutual funds, hedge funds, and other investors is a genuine skill with real consequences: allocate too much to short-term-oriented investors likely to sell the stock quickly (sometimes called "flipping") and the stock can trade down hard in its first days, while allocating too heavily toward large, stable long-only holders builds a more durable shareholder base but can frustrate other investors who feel shut out of a hot deal and may not show up for the company's next offering. The mechanics of building and reading a book, and the judgment calls behind allocation, are covered in how the syndicate desk works.

The third dynamic is the aftermarket itself, the days and weeks immediately after a deal prices, when the stabilization tools the syndicate desk built into the deal actually get used. The greenshoe, an option to sell up to an additional 15% of the deal size, lets underwriters buy stock back in the open market if the price weakens shortly after the offering, supporting the price without the bank taking on unlimited risk. A stock that trades down meaningfully and durably in its first weeks is a bad outcome for everyone involved, since it is the clearest public signal that a deal was priced too aggressively, and it is exactly the kind of outcome interviewers ask candidates to reason through when they pose a scenario question about a deal that "broke," meaning traded below its offer price.

How ECM interviews differ

A generalist technical interview tests comparable companies, a discounted cash flow, and basic accounting. An ECM interview tests all of that, usually at a slightly lighter level of depth than an M&A or leveraged finance interview would, and then adds a layer that has no equivalent elsewhere: real market awareness and a feel for how a deal actually gets done, not just how a company gets valued.

The first difference is that ECM interviewers routinely ask candidates to describe recent activity they have followed in the new-issue market, or to explain, in general terms, why a hypothetical deal might have been well or poorly received. This is not a request to recite specific transactions from memory; it is a test of whether you actually read markets coverage and think about deals as they happen, the same instinct a sales and trading desk screens for, layered onto a banking interview. Candidates who only prepare technical valuation questions and skip building any market fluency are routinely caught flat by this.

The second is a heavier emphasis on process and mechanics questions relative to valuation questions: walk me through how a book gets built, what happens if a deal is oversubscribed by ten times, what a greenshoe actually does, why a convert might make sense for a company that could issue straight debt instead. These questions test operational fluency with how a deal actually gets executed, which is a different skill than building a DCF and one ECM specifically prioritizes because junior ECM bankers are pulled into live execution far earlier and far more often than a typical M&A analyst is.

A closely related third difference is comfort with quick, order-of-magnitude math done out loud. Because ECM decisions get made in real time against a moving stock price, an interviewer will sometimes hand you a rough set of numbers, a deal size, a current share price, a discount percentage, and ask you to work out the resulting share count or dilution on the spot, the way a syndicate banker might need to during an actual roadshow call. This is less about complex modeling and more about not freezing up on simple arithmetic under time pressure, a muscle that a candidate who has only ever built models slowly in Excel sometimes has not developed.

The fourth is the fit question itself, which carries unusually high stakes in ECM specifically because so many candidates default to a generic "I like the stock market" answer that says nothing distinctive. A strong ECM answer names a specific mechanic, pricing tension, or product structure that genuinely interests the candidate and connects it to the actual seat, not just an interest in trading for its own sake, which would arguably describe a sales and trading candidate better than an ECM one. The full structure for building that answer is in how to answer why ECM, and once you can answer it with real specificity, understanding where ECM leads afterward rounds out the picture an interviewer is checking for.

None of this requires memorizing headlines from a given week. It requires understanding, at a mechanical level, how a deal actually gets built, priced, and sold, and being able to reason about why a hypothetical deal would go well or badly under different market conditions. The rest of this guide works through each product and mechanic with that same lens, and the interview questions page collects the specific ways interviewers actually ask about it.